Create Free Account

By creating account you will get access to hot stocks & personalised emails

Austco Healthcare Ltd

Healthcare AU AHC

0.255AUD
-0.005(1.92%)

Last update at 2024-11-13T04:58:00Z

Day Range

0.260.27
LowHigh

52 Week Range

0.170.27
LowHigh

Fundamentals

  • Previous Close 0.26
  • Market Cap92.84M
  • Volume361886
  • P/E Ratio12.75
  • Dividend Yield-%
  • EBITDA6.58M
  • Revenue TTM58.15M
  • Revenue Per Share TTM0.19
  • Gross Profit TTM 22.43M
  • Diluted EPS TTM0.02

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 1.81M 2.63M 3.94M 2.65M 0.09M
Minority interest - - - - -
Net income 2.26M 2.33M 3.42M 2.50M 0.64M
Selling general administrative 14.42M 11.98M 11.16M 10.84M 9.88M
Selling and marketing expenses -12.74500M - - - -
Gross profit 6.68M 18.85M 16.71M 16.44M 14.49M
Reconciled depreciation 1.72M 1.38M 1.03M 0.91M 0.44M
Ebit 1.80M 2.14M 2.10M 2.74M 0.12M
Ebitda 3.52M 3.52M 3.13M 3.65M 0.56M
Depreciation and amortization 1.72M 1.38M 1.03M 0.91M 0.44M
Non operating income net other - - - - -
Operating income 1.80M 2.14M 2.10M 2.74M 0.12M
Other operating expenses 40.17M 33.74M 29.15M 30.29M 31.65M
Interest expense 0.07M 0.05M 0.05M 0.09M 0.03M
Tax provision -0.44300M 0.30M 0.51M 0.15M -0.55000M
Interest income 0.04M 0.02M 0.00800M 0.00400M -
Net interest income -0.02900M -0.03400M -0.04200M -0.08700M -0.03300M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.44300M 0.30M 0.51M 0.15M -0.55000M
Total revenue 41.98M 35.88M 31.25M 31.60M 31.70M
Total operating expenses 4.88M 16.71M 14.61M 15.13M 14.44M
Cost of revenue 35.29M 17.03M 14.54M 15.16M 17.21M
Total other income expense net 0.01M 0.52M 1.88M 1.43M 0.07M
Discontinued operations - - - - -
Net income from continuing ops 2.26M 2.33M 3.42M 2.50M 0.64M
Net income applicable to common shares 2.26M 2.33M 3.42M 2.50M 0.64M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 68.72M 37.81M 34.03M 27.18M 23.09M
Intangible assets - 5.46M 4.68M 3.61M 2.88M
Earning assets - - - - -
Other current assets 1.81M 0.22M 1.54M 1.25M 0.56M
Total liab 24.34M 12.81M 10.94M 7.88M 6.83M
Total stockholder equity 44.38M 25.00M 23.09M 19.30M 16.26M
Deferred long term liab - 5.46M 4.68M 3.61M 2.88M
Other current liab 4.49M 2.57M 3.50M 3.72M 3.47M
Common stock 54.47M 42.19M 41.72M 41.44M 41.44M
Capital stock - 42.19M 41.72M 41.44M 41.44M
Retained earnings -10.62600M -17.85800M -18.90100M -21.27600M -24.74700M
Other liab - 0.05M 0.04M 0.03M 0.01M
Good will 14.49M - - - -
Other assets 0.00000M 7.18M 5.60M 4.37M 3.65M
Cash 13.56M 4.67M 7.63M 7.77M 6.45M
Cash and equivalents - 4.67M 7.63M 7.77M 6.45M
Total current liabilities 17.06M 12.64M 10.49M 7.24M 6.25M
Current deferred revenue 2.67M - 1.44M 1.22M -
Net debt -11.77800M - -6.64900M -6.61700M -5.55500M
Short term debt 0.57M 0.02M 0.56M 0.54M 0.33M
Short long term debt - 0.02M 0.05M 0.03M 0.03M
Short long term debt total 1.78M - 0.98M 1.15M 0.89M
Other stockholder equity - 0.67M 0.27M -0.86300M -0.43000M
Property plant equipment - 0.85M 1.09M 1.15M 1.30M
Total current assets 40.57M 29.79M 27.34M 21.66M 18.14M
Long term investments - - - - -
Net tangible assets - 25.00M 23.09M 19.30M 16.26M
Short term investments - - - - -
Net receivables 14.53M 12.83M 7.62M 6.05M 4.94M
Long term debt - - - - -
Inventory 10.67M 10.83M 9.21M 5.13M 5.25M
Accounts payable 9.32M 8.34M 6.74M 3.62M 2.45M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.54M - 0.27M -0.86300M -0.43000M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 6.26M - - - -
Deferred long term asset charges - - - - -
Non current assets total 28.15M 8.02M 6.70M 5.52M 4.95M
Capital lease obligations - 0.50M 0.93M 1.13M 0.87M
Long term debt total - 0.12M 0.42M 0.61M 0.56M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -1.57300M -1.62900M -1.30200M -1.51300M -1.33900M
Change to liabilities 1.79M 3.13M 0.47M -3.17700M 1.37M
Total cashflows from investing activities -1.57300M -1.62900M -1.30200M -1.51300M -1.33900M
Net borrowings -0.68600M -0.59700M -0.47400M -0.57700M -0.37800M
Total cash from financing activities -1.58300M -0.31200M -0.47400M 2.78M -0.37800M
Change to operating activities 0.80M -0.10200M -1.08100M -0.63600M 0.38M
Net income 2.26M 2.33M 3.42M 2.50M 0.64M
Change in cash -2.95500M -0.14200M 1.32M 4.50M -0.36200M
Begin period cash flow 7.63M 7.77M 6.45M 1.95M 2.31M
End period cash flow 4.67M 7.63M 7.77M 6.45M 1.95M
Total cash from operating activities 0.32M 1.94M 3.21M 3.30M 1.42M
Issuance of capital stock - 0.28M - 3.36M -
Depreciation 1.72M 1.38M 1.03M 0.91M 0.44M
Other cashflows from investing activities - - - - 0.00000M
Dividends paid -0.89700M 0.90M 0.90M 0.90M -
Change to inventory -1.60600M -3.53100M 0.12M 1.50M -0.88100M
Change to account receivables -4.59900M -1.57100M -1.11300M 1.98M -0.63600M
Sale purchase of stock 0.00000M 0.28M 0.00000M 3.36M -
Other cashflows from financing activities -0.66100M -0.57400M -0.47400M -0.31100M -0.37800M
Change to netincome 0.21M 0.44M 0.15M 0.07M 0.08M
Capital expenditures 1.57M 1.63M 1.30M 1.51M 1.34M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -3.86800M -2.03600M -1.41200M -0.11200M 0.91M
Stock based compensation 0.15M 0.19M 0.13M 0.06M 0.00800M
Other non cash items 7.26M 0.25M 0.01M 0.01M 0.07M
Free cash flow -1.25300M 0.32M 1.91M 1.79M 0.08M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AHC
Austco Healthcare Ltd		 -0.005 1.92% 0.26 12.75 - 1.60 2.11 1.41 10.23
RMD
Resmed Inc DRC		 -0.55 1.44% 37.60 32.17 24.81 11.30 7.04 7.59 22.46
FPH
Fisher & Paykel Healthcare Corporation Limited		 -0.26 0.76% 33.95 166.10 51.81 11.13 12.06 12.02 57.37
ANN
Ansell Ltd		 -0.41 1.27% 31.77 35.58 21.01 2.85 1.58 1.82 14.56
NAN
Nanosonics Ltd		 -0.02 0.60% 3.30 81.00 65.79 5.78 5.33 4.96 39.15

Reports Covered

Stock Research & News

View All

Profile

Austco Healthcare Limited, together with its subsidiaries, operates as provider of healthcare communication solutions in Australia, New Zealand, Asia, Europe, and North America. The company offers Tacera, an IP nurse call and clinical communications platform; Medicom, a solution for nurse call system; Pulse Mobile which allows staff to manage nurse call functions on the go and trigger workflows remotely; Built-in RTLS, a nurse call platform; enterprise reporting; and integration services. The company was formerly known as Azure Healthcare Limited and changed its name to Austco Healthcare Limited in November 2020. Austco Healthcare Limited was founded in 1986 and is headquartered in Port Melbourne, Australia.

Austco Healthcare Ltd

31 Sabre Drive, Port Melbourne, VIC, Australia, 3207

Key Executives

Name Title Year Born
Mr. Clayton Astles CEO, MD & Exec. Director NA
Mr. Brendan James Maher CFO & Company Sec. 1968
Mr. Andrew Hall Chief Commercial Officer NA
Mr. Michael Read Gen. Mang. of Australasia NA
Mr. Clayton Astles CEO, MD & Executive Director NA
Mr. Brendan James Maher CFO & Company Secretary 1968
Mr. Clayton Astles CEO, MD & Executive Director NA
Mr. Brendan James Maher CFO & Company Secretary 1968
Mr. Clayton Astles CEO, MD & Executive Director NA
Mr. Brendan James Maher CFO & Company Secretary 1968

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.